Lin Ye
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 5
- Inflammasome and immune disorders 3
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Wnt/β-catenin signaling in development and cancer 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Co-authors
- Gary E. Means (1 shared paper)R.E. Feeney (1 shared paper)Tingxiu Xiang (11 shared papers)Weiyan Peng (6 shared papers)Guosheng Ren (6 shared papers)Zhu Qiu (5 shared papers)Qiangsong Tong (4 shared papers)Liduan Zheng (4 shared papers)
- Journals
- Epigenomics (2 papers)Frontiers in Oncology (2 papers)Theranostics (2 papers)Experimental Biology and Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lin Ye
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 281
- Molecular Biology 647
- Oncology 162
- Biotechnology 52
- Pulmonary and Respiratory Medicine 133
Countries citing papers authored by Lin Ye
This map shows the geographic impact of Lin Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Ye more than expected).
Fields of papers citing papers by Lin Ye
This network shows the impact of papers produced by Lin Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Ye. The network helps show where Lin Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1969 | 214 | |
| 2 | 2021 | 132 | |
| 3 | 2018 | 81 | |
| 4 | 2014 | 75 | |
| 5 | 2017 | 60 | |
| 6 | 2013 | 53 | |
| 7 | 2014 | 49 | |
| 8 | 2020 | 46 | |
| 9 | 2020 | 43 | |
| 10 | 2022 | 42 | |
| 11 | 2021 | 39 | |
| 12 | 2019 | 38 | |
| 13 | 2017 | 29 | |
| 14 | 2018 | 27 | |
| 15 | 2020 | 24 | |
| 16 | 2018 | 21 | |
| 17 | 2019 | 20 | |
| 18 | 2018 | 19 | |
| 19 | 2013 | 18 | |
| 20 | 2018 | 14 |
About Lin Ye
Lin Ye is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Inflammasome and immune disorders (3 papers), RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cancer Research (281 citations), Molecular Biology (647 citations), Oncology (162 citations), Biotechnology (52 citations) and Pulmonary and Respiratory Medicine (133 citations). Lin Ye has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Gary E. Means, R.E. Feeney, Tingxiu Xiang, Weiyan Peng, Guosheng Ren, Zhu Qiu, Qiangsong Tong, Liduan Zheng, Ran Sun and Jun Tang. Their work appears in journals such as Epigenomics, Frontiers in Oncology, Theranostics, Experimental Biology and Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.